These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3698826)

  • 21. Phase I-II study of cisplatin, VP-16, MGBG, mitomycin, and vinblastine with radiation therapy for non-small-cell lung cancer.
    Christian ES; Schreeder M; Salter MM; Stephens SB; Carpenter JT; Wheeler RH
    Am J Clin Oncol; 1988 Aug; 11(4):502-5. PubMed ID: 2841845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B.
    Richards F; Perry DJ; Goutsou M; Modeas C; Muchmore E; Rege V; Chahinian AP; Hirsh V; Poiesz B; Green MR
    Cancer; 1991 Jun; 67(12):2974-9. PubMed ID: 1646066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MVP (mitomycin, vinblastine, and progesterone): a second-line regimen in ovarian cancer with a high incidence of pulmonary toxicity.
    Ozols RF; Hogan WM; Ostchega Y; Young RC
    Cancer Treat Rep; 1983; 67(7-8):721-2. PubMed ID: 6871888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A weekly cisplatin-based induction regimen for extensive non-small cell lung cancer. A Southwest Oncology Group study.
    Higano CS; Crowley J; Livingston RB; Goodwin JW; Barlogie B; Stuckey WJ
    Cancer; 1991 May; 67(10):2439-42. PubMed ID: 1849785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancer.
    Stuart-Harris R; Fox RM; Raghavan D; Coates AS; Hedley D; Levi JA; Woods RL; Tattersall MH
    Thorax; 1985 May; 40(5):346-50. PubMed ID: 2410994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematologic toxicity of cisplatin and mitomycin in combination for squamous cell carcinoma of esophagus.
    Stoll DB; Lavin PT; Engstrom PF
    Am J Clin Oncol; 1985 Jun; 8(3):231-4. PubMed ID: 4050741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
    Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
    Lele SB; Piver MS
    Gynecol Oncol; 1989 Apr; 33(1):6-8. PubMed ID: 2467845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized prospective study of cisplatin and vinblastine versus cisplatin, vinblastine and mitomycin in advanced non-small cell lung cancer.
    Mylonakis N; Tsavaris N; Bacoyiannis C; Karvounis N; Kakolyris S; Karabelis A; Beer M; Kosmidis P
    Ann Oncol; 1992 Feb; 3(2):127-30. PubMed ID: 1318742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H
    Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitomycin C, vinblastine and cis-platin. An active regimen for advanced non-small cell lung cancer.
    Giaccone G; Bagatella M; Donadio M; Bonardi GM; Testore F; Ferrati P; Ciuffreda L; Calciati A
    Br J Cancer; 1987 Oct; 56(4):475-8. PubMed ID: 2825750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pilot combination phase II study of mitomycin C plus cisplatin for non-small cell lung cancer].
    Shimizu E; Kamei T; Kimura K; Mukai J; Nakamura Y; Kunishige E; Fukuta K; Tani K; Sone S; Ogura T
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3719-23. PubMed ID: 2556971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
    Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer.
    Hickish TF; Smith IE; Nicolson MC; Ashley S; Priest K; Spencer L; Norman A; Middleton G; O'Brien ME
    Br J Cancer; 1998 Jun; 77(11):1966-70. PubMed ID: 9667676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Respiratory complications of the vinorelbine-mitomycin combination].
    Rouzaud P; Estivals M; Pujazon MC; Carles P; Lauque D
    Rev Mal Respir; 1999 Feb; 16(1):81-4. PubMed ID: 10091264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy of non small cell lung cancer. A prospectively randomized study of cisplatin-etoposide versus cisplatin-mitomycin-vinblastine.
    Polyzos A; Tsavaris N; Veslemes M; Dardoufas K; Dosios T; Kosmas C
    J Chemother; 1997 Apr; 9(2):102-5. PubMed ID: 9176747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.
    Joss RA; Alberto P; Obrecht JP; Barrelet L; Holdener EE; Siegenthaler P; Goldhirsch A; Mermillod B; Cavalli F
    Cancer Treat Rep; 1984 Sep; 68(9):1079-84. PubMed ID: 6090014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen. A phase II study.
    Tummarello D; Graziano F; Isidori P; Santo A; Cetto G; Fedeli A; Rossi G; Cellerino R
    Cancer; 1996 Jun; 77(11):2251-7. PubMed ID: 8635092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant mitomycin C, cisplatin, and infusion vinblastine in locally and regionally advanced non-small cell lung cancer: problems and progress from the perspective of long-term follow-up.
    Spain RC
    Semin Oncol; 1988 Jun; 15(3 Suppl 4):6-15. PubMed ID: 2839905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials.
    Pisters KM; Kris MG; Gralla RJ; Zaman MB; Heelan RT; Martini N
    J Clin Oncol; 1993 Sep; 11(9):1757-62. PubMed ID: 8394881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.